Hillgene Biopharma ya lashe kyautar '' '2022 China Alishir

A ranar 30 ga Disamba, 2022, "na" 2022 China Biopharmaleuthal Repernancin Insiyawar Insiyawa "a hukumance ta a ranar bude sarkar" na biyu ta kasar Sin da canjin canji. " Jianguwa Hillssu Hillseutene Biopharmaceà Co., Ltd. Ya samu nasarar samun nasarar "kyautar doki" kuma an amince da shi a matsayin "mafi kama da masana'antar fitowar 2022."

Wannan jerin an tattara su ta amfani da bayanai daga wurare daban-daban, gami da sabon bincike na bincike da kayan aikin ci gaba, da kuma bayanan kwayoyi masu magani. Manyan halittar "wani sabon tsarin 'yan kasuwar" na musamman, aikin musamman, an tabbatar da ka'idojin kimantawa, cigaban fasaha, da bincike na asibiti da ci gaba. Wani kwamoran na Ma'aikata da masana sun gudanar da taron bidiyo, zaben kan layi, da kuma auna cikakkiyar cikakkiyar kyaututtuka, da lambobin doki, da kuma lambobin doki na zinare. Wannan jeri ya zama babban lambar kyauta a fagen kirkire-canje da canji a cikin masana'antar kasusuwa.

A matsayin kamfani na farko a kasar da za a ba shi 'yan kwastomomi na cigaba, ingancinsa - Takaddar kwayoyi kwangila da masana'antar kwaro (CQDMO).

Wannan kyautar ba wai kawai nuna kyamarar da ta fifita ta Hilorgene bipharments na Hillgene bipharma ba amma kuma suna da matukar wahayi don kara yawan nasara a filin Cqdmo. A nan gaba, Hildan Hilta Biopharma za ta ci gaba da nufin kafa ka'idodin masana'antu, ingancin samfuran kwastomomi, da tura ci gaban kwayoyi masu samar da kwayar halitta, da kuma turawa da wadannan sabbin hanyoyin kwantar da hankali a kasuwa.

Lokaci: 2023 - 02 - 17 00:00:00